179 related articles for article (PubMed ID: 26261485)
1. Expression of DNA damage checkpoint 53BP1 is correlated with prognosis, cell proliferation and apoptosis in colorectal cancer.
Bi J; Huang A; Liu T; Zhang T; Ma H
Int J Clin Exp Pathol; 2015; 8(6):6070-82. PubMed ID: 26261485
[TBL] [Abstract][Full Text] [Related]
2. 53BP1 loss induces chemoresistance of colorectal cancer cells to 5-fluorouracil by inhibiting the ATM-CHK2-P53 pathway.
Yao J; Huang A; Zheng X; Liu T; Lin Z; Zhang S; Yang Q; Zhang T; Ma H
J Cancer Res Clin Oncol; 2017 Mar; 143(3):419-431. PubMed ID: 27838786
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of 53BP1 inhibits the radiosensitivity of colorectal cancer.
Xiao Y; Zheng X; Huang A; Liu T; Zhang T; Ma H
Int J Oncol; 2016 Oct; 49(4):1600-8. PubMed ID: 27499037
[TBL] [Abstract][Full Text] [Related]
4. 53BP1 loss suppresses the radiosensitizing effect of icotinib hydrochloride in colorectal cancer cells.
Huang A; Yao J; Liu T; Lin Z; Zhang S; Zhang T; Ma H
Int J Radiat Biol; 2018 Apr; 94(4):327-334. PubMed ID: 29388453
[TBL] [Abstract][Full Text] [Related]
5. High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer.
Yi W; Xiao E; Ding R; Luo P; Yang Y
Oncol Rep; 2016 Dec; 36(6):3145-3153. PubMed ID: 27748871
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
Li C; Cai S; Wang X; Jiang Z
Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
[TBL] [Abstract][Full Text] [Related]
7. The p53-inducible gene 3 (PIG3) contributes to early cellular response to DNA damage.
Lee JH; Kang Y; Khare V; Jin ZY; Kang MY; Yoon Y; Hyun JW; Chung MH; Cho SI; Jun JY; Chang IY; You HJ
Oncogene; 2010 Mar; 29(10):1431-50. PubMed ID: 20023697
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of nemo-like kinase is an independent prognostic factor in colorectal cancer.
Zhang W; He J; Du Y; Gao XH; Liu Y; Liu QZ; Chang WJ; Cao GW; Fu CG
World J Gastroenterol; 2015 Aug; 21(29):8836-47. PubMed ID: 26269673
[TBL] [Abstract][Full Text] [Related]
9. 53BP1, a mediator of the DNA damage checkpoint.
Wang B; Matsuoka S; Carpenter PB; Elledge SJ
Science; 2002 Nov; 298(5597):1435-8. PubMed ID: 12364621
[TBL] [Abstract][Full Text] [Related]
10. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer.
Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A
Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979
[TBL] [Abstract][Full Text] [Related]
11. Decreasing CNPY2 Expression Diminishes Colorectal Tumor Growth and Development through Activation of p53 Pathway.
Yan P; Gong H; Zhai X; Feng Y; Wu J; He S; Guo J; Wang X; Guo R; Xie J; Li RK
Am J Pathol; 2016 Apr; 186(4):1015-24. PubMed ID: 26835537
[TBL] [Abstract][Full Text] [Related]
12. Constitutive expression of γ-H2AX has prognostic relevance in triple negative breast cancer.
Nagelkerke A; van Kuijk SJ; Sweep FC; Nagtegaal ID; Hoogerbrugge N; Martens JW; Timmermans MA; van Laarhoven HW; Bussink J; Span PN
Radiother Oncol; 2011 Oct; 101(1):39-45. PubMed ID: 21840613
[TBL] [Abstract][Full Text] [Related]
13. 53BP1 suppresses tumor growth and promotes susceptibility to apoptosis of ovarian cancer cells through modulation of the Akt pathway.
Hong S; Li X; Zhao Y; Yang Q; Kong B
Oncol Rep; 2012 Apr; 27(4):1251-7. PubMed ID: 22266878
[TBL] [Abstract][Full Text] [Related]
14. EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway.
Shen A; Chen Y; Liu L; Huang Y; Chen H; Qi F; Lin J; Shen Z; Wu X; Wu M; Li Q; Qiu L; Yu N; Sferra TJ; Peng J
Cancer Res; 2019 May; 79(9):2257-2270. PubMed ID: 30862720
[TBL] [Abstract][Full Text] [Related]
15. Characterization of SLC22A18 as a tumor suppressor and novel biomarker in colorectal cancer.
Jung Y; Jun Y; Lee HY; Kim S; Jung Y; Keum J; Lee YS; Cho YB; Lee S; Kim J
Oncotarget; 2015 Sep; 6(28):25368-80. PubMed ID: 26196590
[TBL] [Abstract][Full Text] [Related]
16. The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells.
Deng S; Yan T; Nikolova T; Fuhrmann D; Nemecek A; Gödtel-Armbrust U; Kaina B; Wojnowski L
Br J Pharmacol; 2015 May; 172(9):2246-57. PubMed ID: 25521189
[TBL] [Abstract][Full Text] [Related]
17. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
[TBL] [Abstract][Full Text] [Related]
18. STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage.
Townsend PA; Cragg MS; Davidson SM; McCormick J; Barry S; Lawrence KM; Knight RA; Hubank M; Chen PL; Latchman DS; Stephanou A
J Cell Sci; 2005 Apr; 118(Pt 8):1629-39. PubMed ID: 15784679
[TBL] [Abstract][Full Text] [Related]
19. The clinicopathological significance of REIC expression in colorectal carcinomas.
Wang W; Zhu W; Xu XY; Nie XC; Yang X; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC
Histol Histopathol; 2012 Jun; 27(6):735-43. PubMed ID: 22473694
[TBL] [Abstract][Full Text] [Related]
20. 53BP1 regulates cell cycle arrest in esophageal cancer model.
Yang J; Jing L; Liu CJ; Bai WW; Zhu SC
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):604-612. PubMed ID: 30720168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
